Interim report of the reactogenicity and immunogenicity of SARS-CoV-2 XBB-containing vaccines. Chalkias S, McGhee N, Whatley JL, Essink B, et al. J Infect Dis 2024 Feb 13:jiae067. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chalkias S, McGhee N, Whatley JL, Essink B, et al. Interim report of the reactogenicity and immunogenicity of SARS-CoV-2 XBB-containing vaccines. J Infect Dis 2024 Feb 13:jiae067. doi: 10.1093.
PMID: 38349280